Search clinical trials for: Risperidone Long Acting Injectable (LAI)

Total 2287 results

Janssen Pharmaceutical K.K.

Terminated

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Dementia | Alzheimer's Disease
Janssen, LP

Completed

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Janssen-Ortho Inc., Canada

Completed

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

Bipolar Disorder
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

Bipolar Disorder | Manic Disorder
Stony Brook University

Completed

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

Agitation

United States
National Center for Research Resources (NCRR)
Yale University

Completed

Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

Tourette Syndrome
Henry M. Spotnitz
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Optimized Biventricular Pacing Allograft Recipients (BiBET)

Dilated Cardiomyopathy | Ischemic Cardiomyopathy

United States
Semmes-Murphey Foundation

Unknown

Efficacy of Intradiscal Injection of Viable Placental Tissue Extract in Subjects With One or Two Level, Symptomatic Lumbar Intervertebral Disc Degeneration

Pain | Degenerative Disc Disease

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

New Onset Type 1 Diabetes: Role of Exenatide

Type 1 Diabetes

United States
Shanghai Minimally Invasive Surgery Center
Wuxi Branch of Ruijin Hospital; Shanghai OneTar Biomedicine Co., Ltd.

Not yet recruiting

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

Neoadjuvant Therapy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders

Disruptive Behavior Disorder
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Depressive Disorder | Depression | Depressive Disorder, Major
Janssen, LP

Completed

A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

Schizophrenia | Schizoaffective Disorder
Janssen-Ortho Inc., Canada

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)

Autistic Disorder | Developmental Disabilities | Rett Syndrome | Asperger Syndrome | DCild Development Disorders, Pervasive
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia

Dementia | Alzheimer Disease | Dementia, Vascular
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Janssen-Ortho Inc., Canada

Completed

An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone

Schizophrenia
Braeburn Pharmaceuticals

Completed

Safety and Tolerability of Risperidone Implants

Schizophrenia

United States
Braeburn Pharmaceuticals

Completed

Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Schizophrenia | Schizo-affective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

Psychotic Disorders | Schizophrenia
Sanofi
Regeneron Pharmaceuticals

Active, not recruiting

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation (NOTUS)

Chronic Obstructive Pulmonary Disease

Greece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more
Novartis

Completed

Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Germany
Buchinger Wilhelmi Development & Holding GmbH
King's College London; Leiden University Medical Center; ETH Zurich; Claude Bernard... and other collaborators

Completed

Long-term Fasting: Multi-system Adaptations in Humans

Fasting

Germany
Centre for Addiction and Mental Health

Unknown

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Canada
New York State Psychiatric Institute
Columbia University; National Institute on Aging (NIA)

Completed

Antipsychotic Discontinuation in Alzheimer's Disease (ADAD)

Aggression | Psychotic Disorders | Alzheimer Disease | Agitation

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Schizophrenia
Janssen Korea, Ltd., Korea

Completed

The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania

Bipolar Disorder
Capital Medical University

Completed

Risperidone Maintenance Treatment in Schizophrenia

Schizophrenia

China
University of South Florida
Janssen, LP

Completed

A Study of Risperidone Monotherapy in Bipolar Anxiety

Generalized Anxiety Disorder | Bipolar Disorder | Panic Disorder

United States
GlaxoSmithKline

Completed

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Schizophrenia

United States
Duke University
Janssen, LP

Completed

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Schizophrenia | Schizoaffective Disorder

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

Anxiety Disorders
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Bipolar Disorder | Manic Episode
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Bipolar Disorders | Manic Episode
Janssen, LP

Completed

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Schizophrenia | Schizoaffective Disorder
Central Institute of Mental Health, Mannheim

Completed

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Schizophrenia, Schizoaffective Disorder

Germany
University of Turin, Italy

Completed

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors

Neuroendocrine Tumors

Italy
Birte Glenthoj
Icahn School of Medicine at Mount Sinai

Terminated

The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia

Schizophrenia

Denmark
ValiSeek Limited

Completed

A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Adenocarcinoma | Carcinoma, Non-Small-Cell Lung
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia (PRISMA-2)

Schizophrenia

United States
Indivior Inc.

Completed

Single Ascending Dose Study of RBP-7000

Schizophrenia

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Psychotic Disorders | Schizophrenia | Emergency Treatment
Institut de Recherches Cliniques de Montreal
Novo Nordisk A/S; McMaster University

Completed

Levemir-Body Composition and Energy Metabolism

Type 2 Diabetes

Canada
Rovi Pharmaceuticals Laboratories

Recruiting

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (RESHAPE)

Schizophrenia

Germany
Marion Trousselard

Terminated

Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?

Anxiety State

France
University of Geneva, Switzerland

Terminated

Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome

22q11.2 Deletion Syndrome

Switzerland
University of Alabama at Birmingham
Janssen Pharmaceuticals

Completed

Risperidone and Suicidality in Major Depressive Disorder

Depression

United States

3

Subscribe